suck pdf from google scholar
unlimited free pdf from europmc19946434    free
PDF from PMC    free
html from PMC    free
PDF vom PMID19946434 :   free
suck pdf from library genesis
English Wikipedia

Nephropedia Template TP (

Twit Text


  • DeepDyve
  • Pubget Overpricing


  • lüll
  • Treatment of dwarfism with recombinant human insulin-like growth factor-1
  • Ranke MB; Wolfle J; Schnabel D; Bettendorf M
  • Dtsch Arztebl Int 2009[Oct]; 106 (43): 703-9
  • BACKGROUND: The growth hormone-IGF (insulin-like growth factor) system plays a central role in hormonal growth regulation. Recombinant human (rh) growth hormone (GH) has been available since the late 1980s for replacement therapy in GH-deficient patients and for the stimulation of growth in patients with short stature of various causes. Growth promotion by GH occurs in part indirectly through the induction of IGF-1 synthesis. In primary disturbances of IGF-1 production, short stature can only be treated with recombinant human IGF-1 (rhIGF-1). rhIGF-1 was recently approved for this indication but can also be used to treat other conditions. METHODS: Selective review of the literature on IGF-1 therapy, based on a PubMed search. RESULTS AND CONCLUSION: In children with severe primary IGF-1 deficiency (a rare condition whose prevalence is less than 1:10,000), the prognosis for final height is very poor (ca. 130 cm), and IGF-1 therapy is the appropriate form of pathophysiologically based treatment. There is no alternative treatment at present. The subcutaneous administration of IGF-1 twice daily in doses of 80 to 120 microg/kg accelerates growth and increases final height by 12 to 15 cm, according to current data. There is, however, a risk of hypoglycemia, as IGF-1 has an insulin-like effect. As treatment with IGF-1 is complex, this new medication should only be prescribed, for the time being, by experienced pediatric endocrinologists and diabetologists.
  • |Dwarfism/*drug therapy[MESH]
  • |Humans[MESH]
  • |Insulin-Like Growth Factor I/*administration & dosage[MESH]
  • |Recombinant Proteins/*therapeutic use[MESH]





  • *{{pmid19946434}}
    *<b>[http://www.kidney.de/mlpefetch.php?search=19946434 Treatment of dwarfism with recombinant human insulin-like growth factor-1 ]</b> Dtsch Arztebl Int 2009; 106(43) ; 703-9 Ranke MB; Wolfle J; Schnabel D; Bettendorf M

        *19946434*

    Nephropedia PMID record

    Deutsche Wikipedia - im Artikel

    Hier den unten stehenden Textblock hineinkopieren

    Dtsch Arztebl Int

    703 43.106 2009